Recombinant Human IFN-omega

Also known as: IFNWP2, Interferon alpha-II-1, Interferon omega-1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS304*

Cat. No. Size
BMS304 25 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Description

Description: In the human genome, the IFN-omega gene family consists of seven members located on chromosome 9. However, only one of these genes is functional giving rise to the IFN-omega protein, whereas the others are non-functional pseudogenes. The IFN-omega gene is not expressed in unstimulated cells. Viral infection results in expression of the gene giving rise to the N-glycosylated protein consisting of 172 or 174 amino acids and an apparent molecular mass of about 25kDa. A single carbohydrate group consists mainly of biantennary complex oligosaccharides with variable amounts of N-acetyl neuraminic acid. In quantitative terms, IFN-omega is a major component of human leukocyte IFN; with a contribution to its total antiviral activity estimated to be in the range of 10 -15 %.

Details
Reactivity Human
Components 1 vial (25 ug) human IFN-omega
Purity >95% pure prior to addition of human serum albumin
Molecular Mass 20.0 kDa
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
14-8185 B18R Recombinant Protein FA RUO
14-8289 Human IL-28A (IFN lambda 2) Recombinant Protein FA RUO
14-8299 Human IL-29 (IFN lambda 1) Recombinant Protein ELISA, FA RUO
85-86095 STAT Family Activation InstantOne™ ELISA ELISA RUO
References

Citations: Oftedal,Bergithe E.; B›e Wolff,Anette S.; Bratland,Eirik; K„mpe,Olle; Perheentupa,Jaakko; Myhre,Anne Grethe; Meager,Anthony; Purushothaman,Radhika; Ten,Svetlana; Husebye,Eystein S.. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology 2008;129:163-169. (Link)